You are leaving Medscape Education
Cancel Continue
Log in to save activities Your saved activities will show here so that you can easily access them whenever you're ready. Log in here CME & Education Log in to keep track of your credits.
 

CE

The Nurse View on BTK Inhibitors: Optimizing Your Care of Patients with CLL

  • Authors: Deborah Stephens, DO; Josie Montegaard, MSN, NP; Laura Zitella, MS, RN, ACNP-BC, AOCN
  • CE Released: 8/31/2021
  • THIS ACTIVITY HAS EXPIRED
  • Valid for credit through: 8/31/2022
Start Activity


Target Audience and Goal Statement

This activity is intended for nurses, nurse practitioners, and others involved in the care of patients with chronic lymphocytic leukemia.

The goal of this activity is to improve the knowledge of nurses and nurse practitioners about the role of Bruton tyrosine kinase (BTK) inhibitors in the management of chronic lymphocytic leukemia, as well as enhance their skills in both managing side effects and providing patient and family education.

Upon completion of this activity, participants will:

  • Have increased knowledge regarding the
    • Role of BTK inhibitors in the management of CLL
  • Have greater competence related to
    • Managing side effects of BTK inhibitors in patients with CLL
  • Demonstrate greater confidence in their ability to
    • Help patients overcome barriers to treatment adherence


Disclosures

As an organization accredited by the ACCME, Medscape, LLC requires everyone who is in a position to control the content of an education activity to disclose all relevant financial relationships with any commercial interest. The ACCME defines "relevant financial relationships" as financial relationships in any amount, occurring within the past 12 months, including financial relationships of a spouse or life partner, that could create a conflict of interest.

Medscape, LLC encourages Authors to identify investigational products or off-label uses of products regulated by the US Food and Drug Administration, at first mention and where appropriate in the content.


Faculty

  • Deborah Stephens, DO

    Assistant Professor
    Division of Hematology and Hematologic Malignancies
    University of Utah
    Huntsman Cancer Institute
    Salt Lake City, Utah

    Disclosures

    Disclosure: Deborah Stephens, DO, has the following relevant financial relationships:
    Advisor or consultant for: Adaptive; BeiGene; Epizyme; Innate; Karyopharm; TG Therapeutics
    Grants for clinical research from: Acerta; ArQule; Iovance; Juno; Karyopharm; MingSight

  • Josie Montegaard, MSN, NP

    Nurse Practitioner
    Dana-Farber Cancer Center
    Boston, Massachusetts

    Disclosures

    Disclosure: Josie Montegaard, MSN, NP, has the following relevant financial relationships:
    Advisor or consultant for: AbbVie; AstraZeneca; Janssen; Pharmacyclics

  • Laura Zitella, MS, RN, ACNP-BC, AOCN

    Associate Clinical Professor
    University of California San Francisco
    Hematology/Oncology Nurse Practitioner
    San Francisco, California

    Disclosures

    Disclosure: Laura Zitella, MS, RN, ACNP-BC, AOCN, has no relevant financial relationships.

Editor

  • Lisa Cockrell, PhD

    Medical Education Director, Medscape, LLC

    Disclosures

    Disclosure: Lisa Cockrell, PhD, has disclosed no relevant financial relationships.

CE Reviewer/Nurse Planner

  • Stephanie Corder, ND, RN, CHCP

    Associate Director, Accreditation and Compliance, Medscape, LLC

    Disclosures

    Disclosure: Stephanie Corder, ND, RN, CHCP, has disclosed no relevant financial relationships.

None of the nonfaculty planners for this educational activity have relevant financial relationship(s) to disclose with ineligible companies whose primary business is producing, marketing, selling, reselling, or distributing healthcare products used by or on patients.


Accreditation Statements



In support of improving patient care, Medscape, LLC is jointly accredited by the Accreditation Council for Continuing Medical Education (ACCME), the Accreditation Council for Pharmacy Education (ACPE), and the American Nurses Credentialing Center (ANCC), to provide continuing education for the healthcare team.

    For Nurses

  • Awarded 0.50 contact hour(s) of nursing continuing professional development for RNs and APNs; 0.50 contact hours are in the area of pharmacology.

    Contact This Provider

  • Awarded 0.50 contact hour(s) of nursing continuing professional development for RNs and APNs; 0.50 contact hours are in the area of pharmacology.

For questions regarding the content of this activity, contact the accredited provider for this CME/CE activity noted above. For technical assistance, contact [email protected]


Instructions for Participation and Credit

There are no fees for participating in or receiving credit for this online educational activity. For information on applicability and acceptance of continuing education credit for this activity, please consult your professional licensing board.

This activity is designed to be completed within the time designated on the title page; physicians should claim only those credits that reflect the time actually spent in the activity. To successfully earn credit, participants must complete the activity online during the valid credit period that is noted on the title page. To receive AMA PRA Category 1 Credit™, you must receive a minimum score of 70% on the post-test.

Follow these steps to earn CME/CE credit*:

  1. Read about the target audience, learning objectives, and author disclosures.
  2. Study the educational content online or print it out.
  3. Online, choose the best answer to each test question. To receive a certificate, you must receive a passing score as designated at the top of the test. We encourage you to complete the Activity Evaluation to provide feedback for future programming.

You may now view or print the certificate from your CME/CE Tracker. You may print the certificate, but you cannot alter it. Credits will be tallied in your CME/CE Tracker and archived for 6 years; at any point within this time period, you can print out the tally as well as the certificates from the CME/CE Tracker.

*The credit that you receive is based on your user profile.

CE

The Nurse View on BTK Inhibitors: Optimizing Your Care of Patients with CLL

Authors: Deborah Stephens, DO; Josie Montegaard, MSN, NP; Laura Zitella, MS, RN, ACNP-BC, AOCNFaculty and Disclosures
THIS ACTIVITY HAS EXPIRED

CE Released: 8/31/2021

Valid for credit through: 8/31/2022

processing....

A Powerpoint version of the slides from this presentation
is available for use as a professional resource from Medscape Education.

  • Print